|
시장보고서
상품코드
2008020
바이오의약품용 일회용 제품 시장 : 제품 유형별, 최종사용자별, 지역별Single Use Products in Biopharmaceuticals Market, By Product Type, By End User, By Geography |
||||||
바이오의약품용 일회용 제품 시장 규모는 2026년에 217억 달러로 추계되고 있으며, 2033년까지 344억 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 11.7%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 217억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년의 예측 기간 CAGR : | 11.70% | 2033년 시장 규모 예측 : | 344억 달러 |
바이오의약품 제조 공정에서 사용되는 일회용 제품은 한 번 사용한 후 폐기되는 제품을 의미하며, 이러한 일회용 제품은 제조 목적으로 재사용할 수 없습니다. 이러한 일회용 제품 제조에 사용되는 재료는 플라스틱, 폴리에틸렌, 여과 장치용 종이 등입니다. 일회용 제품은 고가의 장비 비용과 세포배양시 오염 위험을 줄이고, 제조, 테스트, 검증 및 문서화에 소요되는 시간을 줄여줍니다. 의약품 개발, 백신 생산, 기타 의료 혁신으로 인해 전 세계에서 바이오의약품 시장이 급성장하고 있으며, 바이오의약품 제조 공정에 필요한 일회용 제품 시장을 촉진할 것으로 예상됩니다.
시장 역학
시장 진입 업체들은 타사와의 제휴를 통해 바이오의약품 일회용 제품 시장 진출을 확대하고 있으며, 이는 예측 기간 중 글로벌 바이오의약품 일회용 제품 시장의 성장을 더욱 견인할 것으로 예상됩니다. 예를 들어 2021년 9월 9일, 치료제 개발 및 제조에 사용되는 기술 및 서비스 제공 업체인 Cytiva는 중국에서 바이오의약품 일회용 제품 생산 능력을 확대하기로 결정했습니다. Cytiva는 헬스케어 기술 공급업체인 Wego Pharmaceutical Co., Ltd와의 제휴를 통해 아시아태평양내 일회용 제품 공급 능력을 3배로 확대할 예정입니다.
제약 시장의 연구개발 및 투자 활동이 증가함에 따라 일회용 제품에 대한 수요가 증가하고 있으며, 이는 예측 기간 중 글로벌 바이오의약품 일회용 제품 시장의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2021년 12월 7일 발표된 인도 브랜드 주식 재단(IBEF)의 데이터에 따르면 인도 정부는 제약 산업에 대한 정책적 지원을 하고 있으며, 인도 재무부는 2021년 6월 연구개발 활동을 확대하기 위해 향후 5년간 265억 7,830만 달러의 자금을 지원한다고 발표했습니다. 지원한다고 발표했습니다.
본 조사의 주요 특징.
- 세계의 바이오의약품용 일회용 제품 시장에 대해 조사 분석했으며, 2025년을 기준연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 예측하여 전해드립니다.
- 이 보고서는 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계의 바이오의약품 일회용 제품 시장의 주요 기업을 분석합니다. 구체적으로 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 및 전략, 향후 계획 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 바이오의약품 일회용 제품 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 개요
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 바이오의약품용 일회용 제품 시장 : 제품 유형별, 2026-2033년
제5장 세계의 바이오의약품용 일회용 제품 시장 : 최종사용자별, 2026-2033년
제6장 세계의 바이오의약품용 일회용 제품 시장 : 지역별, 2026-2033년
제7장 경쟁 구도
제8장 섹션
KSASingle Use Products In Biopharmaceuticals Market is estimated to be valued at USD 21.7 Bn in 2026 and is expected to reach USD 34.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 21.7 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.70% | 2033 Value Projection: | USD 34.4 Bn |
Single use products used in biopharmaceutical manufacturing process can refer to a product that is used only once and then discard, these single use products cannot be reused for processing purposes. The materials used for manufacturing these single use products are plastic, polyethylene, paper for filtration unit. Single use products reduces the expenses of high cost equipment, risk of contamination in cell culture, reducing the time, testing, validation, and documentation of manufacturing product. As biopharmaceutical market is booming globally for drug development, vaccine production, and other medicinal innovations, this is expected to drive the market of single use products required in biopharmaceutical processing.
Market Dynamics
Market players are expanding their single use products in biopharmaceuticals market with collaborations with other companies, which is further expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on September 9, 2021, Cytiva, a provider of technologies and services used in development and manufacture in therapeutics, decided to expand its manufacturing capacity of single use product in biopharmaceutical in China. In collaboration with Wego Pharmaceutical Co., which is a supplier of healthcare technologies will triple the supply capacity of single use product in Asia Pacific by Cytiva.
The increasing research and development, investment activities in pharmaceutical market increases the requirement of single use products and this is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, According to India Brand Equity Foundation (IBEF) data published on December 7, 2021, in which reports that the Indian government has provided policy assistance to the pharmaceutical business, with the Ministry of Finance of India announcing US$ 26,578.3 million in financing for the next five years to increase research and development operations in June 2021.
Key features of the study
- This report provides an in-depth analysis of global single use products in biopharmaceutical market, provides market size (USD Bn), and compound annual growth rate (CAGR %) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global single use products in biopharmaceutical market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Aber instruments, Adolf Kuhner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor , Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex, and Single Use Support GmbH.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global single use products in biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use products in biopharmaceutical market
Market Segmentation
- By Product Type
- Work Equipment
- Flask
- Containers
- Syringes
- Pipettes tips
- Centrifuge tubes
- Hand Gloves
- Face Mask
- Filters
- Tubes
- Others
- Apparatus
- Single Use Bioreactor
- Isolators
- Membrane Valves
- Canister
- Chromatography Systems
- Filtration Systems
- Mixing Systems
- Others
- By End User
- Pharmaceutical Companies
- Biotechnology Companies and Research Institutes
- By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Aber instruments
- Adolf Kuhner AG
- Thermo Fisher Scientific
- Bio-equip
- Pall corp.
- C-Cit Sensors AG
- Corning Life Sciences
- Eppendorf
- GE Healthcare
- Gemu GmbH
- Merck
- Avantor
- Meissner
- New Horizon Biotech
- PBS-Biotech
- Xcellerex
- Single Use Support GmbH.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Regulatory Scenario
- PEST Analysis
- Recent Product Launch/Approval
- Epidemiology
- Mergers and Acquisitions
4. Global Single Use Products in Biopharmaceuticals Market, By Product Type, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Work Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Flask
- Containers
- Syringes
- Pipettes Tips
- Centrifuge Tubes
- Hand Gloves
- Face Mask
- Filters
- Tubes
- Others
- Apparatus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Single Use Bioreactor
- Isolators
- Membrane Valves
- Canister
- Chromatography Systems
- Filtration Systems
- Mixing Systems
- Others
5. Global Single Use Products in Biopharmaceuticals Market, By End User, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
- Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Single Use Products in Biopharmaceuticals Market, By Region, 2026-2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2021-2033 (USD Bn)
- Market Size and Forecast, By End User, 2021-2033 (USD Bn)
- Market Size and Forecast, By Country, 2021-2033 (USD Bn)
- South Africa
- Central Africa
- North Africa
7. Competitive Landscape
- Company Profiles
- Aber instruments
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Adolf Kuhner AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Thermo Fisher Scientific
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bio-equip
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pall corp
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- C-Cit Sensors AG
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Corning Life Sciences
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Eppendorf
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GE Healthcare
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Gemu GmbH
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Avantor
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Meissner
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- New Horizon Biotech
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- PBS-Biotech
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Xcellerex
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Single Use Support GmbH.
- Company Overview
- Drug Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Analyst Views
- Aber instruments
8. Section
- References
- Research Methodology
- About us and Sales Contact
